New Enzyme ApPT Revolutionizes Drug Development with Precision Modifications

Scientists have uncovered a groundbreaking enzyme called ApPT that could transform drug development. The discovery, led by researchers Zhang, Chen, Wang, and their team, allows precise chemical modifications to complex molecules known as pentacyclic triterpenoids (PTs). These compounds hold promise for therapies but have long been difficult to alter due to their intricate structures. The team identified ApPT using a bioinformatics pipeline designed to speed up the search for enzymes that modify terpenes. This approach merges data-driven biology with traditional enzymology, making it easier to find biocatalysts for late-stage functionalisation of polycyclic terpenoids. The enzyme stands out for its ability to selectively hydroxylate aliphatic sites on PTs—areas previously hard to target—while maintaining strict control over the molecule's three-dimensional shape.

ApPT operates under mild conditions, producing fewer unwanted byproducts and aligning with green chemistry principles. Its precision in oxidising specific carbon-hydrogen bonds opens doors for creating new PT derivatives that were once synthetically impractical. This chemo-enzymatic method bridges biocatalysis with conventional chemical synthesis, offering a more efficient route to novel compounds. Beyond PTs, the bioinformatics strategy used to discover ApPT provides a scalable model for enzyme discovery across other natural product classes. This could accelerate advancements in enzyme engineering and therapeutic innovation. For example, PTs like those in Reishi mushrooms—studied for antioxidative effects and cell regeneration—might now be modified to improve their bioavailability, potentially moving them closer to clinical use.

The discovery of ApPT simplifies the modification of complex PTs, enabling finer control over their therapeutic properties. By combining computational tools with enzymology, researchers have created a method that could broaden the use of these bioactive molecules in medicine. The approach also sets a foundation for discovering and engineering enzymes across a wider range of natural products.